Navigation Links
Doctor Evidence, LLC Closes 2012 With Strong Sales Growth
Date:6/14/2013

Santa Monica, CA (PRWEB) June 14, 2013

Doctor Evidence, LLC continued its multiple-year trend of sustained growth with sales bookings increased over 163% year-over-year from 2011 to 2012. Revenue growth represented an increase of 100% in the same period.

Doctor Evidence’s 2012 success can be attributed both to the expansion of existing projects as well as the start of new initiatives with a varied list of clients, including academic groups, provider networks, managed care organizations, and nine of the top ten medical manufacturers (life science and device).

Among 2012 achievements was the continued collaboration between Doctor Evidence and distinguished healthcare organizations—such as Kaiser Permanente—on the development of the Guidelines Consortium, which enlists the capabilities of the Doctor Evidence product suite to create and share evidence-backed guidelines with colleagues all over the world. A wider rollout is planned for Q3 2013, with several large and prominent healthcare transformation systems joining the Doctor Evidence Guideline Consortium Network. The Guideline Consortium Network will be featured to a global audience of stakeholders at the upcoming Guidelines International Network (GIN) Conference in San Francisco, California in August 2013.

The past year also saw the launch and refinement of Doctor Evidence’s groundbreaking DOC™ Label product, which enables clients in the regulatory affairs and labeling departments of institutions to save, search, and compare over 23,000 prescription drug labels and label versions from the FDA in minutes rather than the hours or even days a more traditional search would require.

About Doctor Evidence, LLC

Doctor Evidence is a specialty software platform and services company aimed to assist stakeholders across the healthcare ecosystem to make and inform clinical and business decisions with the most relevant medical evidence. The Doctor Evidence methodology uses a Digital Outcome Conversion (DOC™) approach of taking data from published clinical studies, FDA drug labels, and epidemiological databases to transform static data into reusable, dynamic relational databases. Our software platform empowers both public and private sector clients to identify the most relevant literature and conduct ready analyses with the highest level of transparency available for today's evidence-based medicine methodological standards in the pursuit of reducing healthcare costs while increasing the quality of patient outcomes.

Doctor Evidence serves decision makers in two large addressable market segments: Medical Manufacturers and Healthcare Providers for the ultimate wellbeing of patients. Doctor Evidence is helping to transform the healthcare ecosystem by identify the most efficacious and safe medical treatment on a comparative effectiveness basis, including related economic costs and total-cost-of-care analysis.

Read the full story at http://www.prweb.com/releases/2013/6/prweb10818390.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Happy Father's Day From Dr. Bob, "The Drugless Doctor" Offering Noteworthy Health Tips
2. Innovative Approach to Healthcare through Telemedicine by Online USA Doctors
3. Just What the Doctor Ordered: GW MFA’s EpiCURE with Chef MDs Nabs National Telly Award
4. Medical Doctor Studies, Inc Announces Open House Meetings
5. Online USA Doctors Introduces a Convenient and Affordable Alternative to Office Visits with Primary Care Physicians
6. Online USA Doctors Launches New Telemedicine Based Healthcare Plans; an Affordable Alternative to Health Insurance
7. Reynolds grant supports aging education of doctors
8. Internationally Recognized Ayurvedic Doctor Akhilesh Sharma Visits Bogota, Colombia
9. Almost Half of Cancer Doctors Report Symptoms of Burnout: Survey
10. Corporate Whistle Blower Center Urges ER Doctors Or Hospital Staff To Turn In Hospitals That Are Needlessly Admitting Patients-For Huge Whistleblower Rewards
11. Fertility Solutions Welcomes a New Doctor, Dr. Vasiliki Moragianni
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... 2016 , ... Finally, a bruise cream that really works. Originally designed ... into the post-surgical treatment plans of a variety of other procedures including, but not ... effective for bruising and causes a rapid resolution of bruising and inflammatory changes compared ...
(Date:6/24/2016)... ... June 24, 2016 , ... Today, InhaleLabs.com (Inhale) offilially ... their medication by matching users with high quality water pipes within an ideal price ... commitment. , Inhale was founded by two brothers, Nick and Mike Hunter, who use ...
(Date:6/23/2016)... ... June 23, 2016 , ... Terumo BCT, ... organization responsible for clinical transfusion research programs and for the blood supply in ... Evaluation and Predictive Analytical Rating Score (PREPAReS) study. , Currently in its ...
(Date:6/23/2016)... ... June 23, 2016 , ... The Mechille Wilson Agency, ... throughout Jasper County and the surrounding region, is initiating a charity drive to assist ... raise funds earmarked for a scholarship fund that will be presented to the chosen ...
(Date:6/23/2016)... , ... June 23, 2016 , ... Representatives of CHA ... the newest member of their staff, Dr. Joshua J. Berger. As of May ... of the world-renowned facility. , Dr. Berger has received recognition for his research, his ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016  Global Blood Therapeutics, Inc. (GBT) (NASDAQ: ... novel therapeutics for the treatment of grievous blood-based ... closing of its previously announced underwritten public offering ... public offering price of $18.75 per share. All ... by GBT. GBT estimates net proceeds from the ...
(Date:6/24/2016)... 24, 2016 ... the addition of the " Global Markets for ... This report focuses on ... updated review, including its applications in various applications. The ... which includes three main industries: pharmaceutical and biotechnology, food ...
(Date:6/24/2016)... , June 24, 2016 The Academy of ... recommendations that would allow biopharmaceutical companies to ... entities that make formulary and coverage decisions, a move ... of new medicines. The recommendations address restrictions ... appear on the drug label, a prohibition that hinders ...
Breaking Medicine Technology: